These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1718588)

  • 41. Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.
    Braunschweiger PG; Jones SA; Johnson CS; Furmanski P
    Cancer Res; 1991 Oct; 51(20):5454-60. PubMed ID: 1913664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex.
    Teicher BA; Abrams MJ; Rosbe KW; Herman TS
    Cancer Res; 1990 Nov; 50(21):6971-5. PubMed ID: 2208163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modification of radio-thermo-chemotherapy by AK-2123 and hydralazine in tumor bearing mice.
    Kunugita N; Mei N; Norimura T; Kagiya TV
    Indian J Exp Biol; 1996 Sep; 34(9):838-41. PubMed ID: 9014514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of mouse sarcoma-180 to bleomycin in combination with radiation and hyperthermia.
    Devi PU; Rao BS
    Strahlenther Onkol; 1993 Oct; 169(10):601-7. PubMed ID: 7694382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
    Kusumoto T; Holden SA; Ara G; Teicher BA
    Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.
    Kim JH; Kim SH; Alfieri A; Young CW; Silvestrini B
    Oncology; 1984; 41 Suppl 1():30-5. PubMed ID: 6717892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple adjuvant therapy on a murine fibrosarcoma: actinomycin-D, X-irradiation and local tumor hyperthermia.
    Alfieri AA; Hahn EW; Kim JH; Lehman D
    Radiology; 1978 Oct; 129(1):225-7. PubMed ID: 693882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the mode of heat induction modify drug anti-tumour effects?
    Hahn GM
    Br J Cancer Suppl; 1982 Mar; 5():238-42. PubMed ID: 6175326
    [No Abstract]   [Full Text] [Related]  

  • 52. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA; Holden SA; Herman TS; Frei E
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
    Herman TS; Teicher BA; Holden SA
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Consideration of simultaneous combination chemotherapy--employing a sensitivity test in Dunn osteosarcoma and NR fibrosarcoma by intra-test tube contact of tumor cell suspension, and subcutaneous inoculation].
    Inoue O; Ibaraki K; Shimabukuro H; Shingaki Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2781-7. PubMed ID: 2074388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo.
    Teicher BA; Holden SA; Liu CJ; Ara G; Herman TS
    Cancer Lett; 1994 Jul; 82(1):17-25. PubMed ID: 8033065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
    Schwartz GN; Teicher BA; Eder JP; Korbut T; Holden SA; Ara G; Herman TS
    Cancer Chemother Pharmacol; 1993; 32(6):455-62. PubMed ID: 8258194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subrenal capsule assay applied to examine the sensitivity of allogenic mouse fibrosarcoma to hyperthermia, chemotherapeutic drugs or combined treatment.
    Sato S; Ootsuyama A; Hamada M; Tanooka H
    Int J Hyperthermia; 1987; 3(2):177-82. PubMed ID: 3110329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
    Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E
    Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma.
    Bloch WE; Lokeshwar BL; Ferrell SM; Block NL
    Prostate; 1994; 24(3):131-8. PubMed ID: 8115278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine.
    Kim JH; Alfieri A; Kim SH; Young CW; Silvestrini B
    Oncology; 1984; 41 Suppl 1():36-8. PubMed ID: 6717893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.